Literature DB >> 4851417

Diurnal variations of serum insulin, total glucagon, cortisol, glucose and free fatty acids in normal and diabetic subjects before and after treatment with chlorpropamide.

L Loreti, T Sugase, P P Foà.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4851417     DOI： 10.1159/000178641

Source DB:  PubMed          Journal:  Horm Res        ISSN： 0301-0163


× No keyword cloud information.
  6 in total

1.  Tolbutamide-induced changes of the DNA, protein and insulin content and the secretory activity of isolated rat pancreatic islets.

Authors:  P Schauder; H Frerichs
Journal:  Diabetologia       Date:  1975-08       Impact factor: 10.122

Review 2.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

Review 3.  Oral hypoglycaemic agents. An update.

Authors:  A C Asmal; A Marble
Journal:  Drugs       Date:  1984-07       Impact factor: 9.546

4.  Glipizide versus tolbutamide, an open trial. Effects on insulin secretory patterns and glucose concentrations.

Authors:  S E Fineberg; S H Schneider
Journal:  Diabetologia       Date:  1980-01       Impact factor: 10.122

5.  Diurnal plasma free fatty acid profiles in normal and diabetic pregnancies.

Authors:  M D Gillmer; R W Beard; N W Oakley; F M Brooke; M C Elphick; D Hull
Journal:  Br Med J       Date:  1977-09-10

6.  Dapagliflozin stimulates glucagon secretion at high glucose: experiments and mathematical simulations of human A-cells.

Authors:  Morten Gram Pedersen; Ingela Ahlstedt; Mickaël F El Hachmane; Sven O Göpel
Journal:  Sci Rep       Date:  2016-08-18       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.